A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy - Quiz - MDSpire

A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy

  • By

  • Jan Kuska

  • Julia Kostyra

  • Lorraine Pinot

  • Evgeny Egorov

  • Nojan Jelveh

  • Lilian A. Martinez Carrera

  • Congcong Zhang

  • Svetlana Khorkova

  • Mario Assenmacher

  • Rimas Orentas

  • Sabine Mueller

  • José Villacorta Hidalgo

  • May 22, 2026

  • 0 min

Share

Original Source(s)

A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy

  • by Jan Kuska, Julia Kostyra, Lorraine Pinot, Evgeny Egorov, Nojan Jelveh, Lilian A. Martinez Carrera, Congcong Zhang, Svetlana Khorkova, Mario Assenmacher, Rimas Orentas, Sabine Mueller, José Villacorta Hidalgo

  • May 22, 2026

Related Content

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

FOXA2 in cancer: from fundamental biology to clinical translation